论文部分内容阅读
目的观察依达拉奉联合复方麝香注射液治疗急性脑梗死的疗效。方法选择2008年1月-2010年12月医院收治的急性脑梗死患者96例,随机分为治疗组和对照组,在治疗前后对患者进行神经功能缺损评分和日常生活能力评价,统计分析不同处理对急性脑梗死疗效的差别。结果治疗2周后,治疗组神经功能缺损评分和日常生活能力改善均显著高于对照组(P<0.05),治疗后两组显效率和总有效率比较差异有统计学意义(P<0.05)。结论依达拉奉联合复方麝香注射液可明显改善急性脑梗死患者神经功能评分和生活能力评分。
Objective To observe the therapeutic effect of edaravone and compound musk injection on acute cerebral infarction. Methods Ninety-six patients with acute cerebral infarction admitted from January 2008 to December 2010 in our hospital were randomly divided into treatment group and control group. Neurological deficit score and daily living ability were evaluated before and after treatment. Statistical analysis of different treatment Differences in the efficacy of acute cerebral infarction. Results After 2 weeks of treatment, the improvement of neurological deficit score and daily living ability in the treatment group were significantly higher than those in the control group (P <0.05). After treatment, the apparent effective rate and total effective rate of the two groups were significantly different (P <0.05) . Conclusion Edaravone combined with compound musk injection can significantly improve the score of neurological function and life ability of patients with acute cerebral infarction.